Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial
Monica Dragoman(Gynuity Health Projects), Metin Gülmezoglu(World Health Organization), Minh Nguyen Thi Hong(Vietnam National Children's Hospital), Jean-Louis Yoko, Anand Tamang(Ministry of Health and Population), Ndema Habib(World Health Organization), Lan Dung Duong(Vietnam National Children's Hospital), My Huong Nguyen(World Health Organization), Nathalie Kapp(International Planned Parenthood Federation), Daniel Grossman(University of California, San Francisco), Tshego Bessenaar(Ibis Reproductive Health), Jageshwor Gautam
Cited by 8
Related Papers
WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity
|BMC Public Health|2006|756
Medical methods for first trimester abortion
|Cochrane Database of Systematic Reviews|2011|288
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
|Reproductive Health|2013|161
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men
|The Journal of Clinical Endocrinology & Metabolism|2016|139